ELTPElite Pharmaceuticals, Inc.

About Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals, Inc. (ELTP) is a Drug Manufacturers - Specialty & Generic company headquartered in Northvale, NJ, United States whose shares trade over-the-counter on the OTCQB tier.

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and distributes niche generic products. Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to third-party pharmaceutical marketing and distribution organizations. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.

Products and services

Elite a specialty pharmaceutical company principally engaged in the development and manufacture of oral, controlled-release generic products, using proprietary know-how and technology. Our strategy includes improving off-patent drug products for life cycle management, developing generic versions of controlled-release drug products with high barriers to entry and exploiting our proprietary and patented abuse resistance technologies. We occupy manufacturing, warehouse, laboratory and office space at 165 Ludlow Avenue and 135 Ludlow Avenue in Northvale, NJ (the “Northvale Facility”). The Northvale Facility operates under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development and manufacturing.

ELTP key facts

Ticker symbol

ELTP

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Northvale, NJ, United States

Country of incorporation

US

Year of incorporation

2012

Employees

64

Estimated market cap

$433.80M (as of Apr 9, 2025)

Shares outstanding

1,068,363,108

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

3/31

Elite Pharmaceuticals, Inc. leadership

• Nasrat Hakim — CEO, President, Other
• Carter J. Ward — CFO, Company Secretary, Treasurer
• Doug Plassche — EVP, Ops.
• Kirko Dimitrov Kirkov — CCO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with E